Radio Havana Cuba

A friendly voice around the world

  • Follow Us on

#NoMasBloqueo #SolidaridadVsBloqueo

Clinical Trial Begins in U.S. for Cuban Lung Cancer Vaccine

New York, January 7 (RHC-Agencies)-- Roswell Park Cancer Institute in Buffalo, New York, has launched the first clinical trial in the United States to study the CIMAvax-EGF vaccine, a lung cancer treatment that was developed in Cuba. Roswell Park is then the only facility in the United States that offers this groundbreaking treatment.

CIMAvax-EGF vaccine is a lung cancer treatment that was developed by researchers with the Havana-based Molecular Immunology Center. The medication is a type of therapy that harnesses the body’s immune system to fight lung cancer.

The current trial is a Phase I out of II study of the CIMAvax-EGF vaccine in combination with the Anti-PD1 checkpoint inhibitor nivolumab in patients previously treated for advanced non-small cell lung cancer (NSCLC).

Edited by Pavel Jacomino
Commentaries
MAKE A COMMENT
  • Cuban president rejects U.S. interference
  • Cuban scholar: the Trump administration will fail because they do not understand Cuba's reality
  • RHC's Caribbean Outlook Show
  • RHC's Arts Roundup
  • In Brazil, weapons may be freely used
  • Cuba warns Title III of Helms-Burton would violate international law and trade norms
NUMBER OF HITS/VISITORS

5559462

  • Max: 19729
  • yesterday: 2791
  • today: 2682
  • online: 149
  • total: 5559462